A Bill Gates-funded effort to develop a livestock vaccine for the prevention of cow flatulence would face resistance if it were imposed on American cattlemen, according to ranchers.
ArkeaBio, the Boston-based developer of the vaccine, has already raised $26.5 million in venture capital funding, reportedly led by an investment fund founded by Mr. Gates. However, if implemented, the new cow vaccine could damage the American cattle supply, according to Justin Tupper, president of the United States Cattlemen’s Association.
